Immunometabolic signatures of BCG-induced neonatal trained immunity
BCG 诱导的新生儿训练免疫力的免疫代谢特征
基本信息
- 批准号:10664100
- 负责人:
- 金额:$ 17.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-06 至 2028-06-01
- 项目状态:未结题
- 来源:
- 关键词:Acetyl Coenzyme AAdultAdvisory CommitteesAgeAttenuatedAwardBCG LiveBCG VaccineBioenergeticsBiological AssayBirthBlood specimenBostonCause of DeathChildhoodCommunicable DiseasesComplementDataDevelopmentDiseaseEnzyme Inhibitor DrugsEnzymesEpigenetic ProcessExposure toFundingFutureGlycolysisGoalsHealthHealth BenefitHumanImmuneImmune ToleranceImmune systemImmunityImmunizationImmunizeImmunologic MemoryImmunologyImpairmentIn VitroInfantInfectionInfection preventionInterventionIsraelLeukocytesLifeLinkLipidsMass Spectrum AnalysisMediatingMediatorMedical centerMentorsMentorshipMetabolicMetabolic PathwayMetabolismMolecularMolecular ProfilingMorbidity - disease rateMycobacterium bovisNational Institute of Allergy and Infectious DiseaseNeonatalNeonatal MortalityNeonatologyNewborn InfantParticipantPathway interactionsPediatric HospitalsPediatricsPeripheralPhenotypePlasmaProgram DevelopmentPublishingResearchRespiratory Tract InfectionsScientistSepsisShapesSmall Interfering RNAStimulusSuccinatesSystems BiologyTechniquesTrainingTuberculosisTuberculosis VaccinesVaccinationVaccinesVulnerable PopulationsWhole BloodWorkWorld Health Organizationadaptive immunityalpha ketoglutaratecareercareer developmentchemokineclinical trainingcofactorcohortcytokineepidemiology studyexperienceexperimental studyhuman modelimmune activationimmunoregulationin vitro Assayin vitro Modelin vivoinnate immune mechanismsinsightinstructormedical schoolsmetabolomemetabolomicsmonocytemortalitymultidisciplinaryneonatal humanneonatal immunityneonatal morbidityneonatenovelpathogenpreventprogramsrandomized trialreceptorresponseskillsvaccine developmentvaccine formulationvaccine responsevaccinology
项目摘要
Project Summary/Abstract
This proposal presents a 5-year research career development program focused on the study of Bacille Calmette-
Guérin (BCG) vaccine and the mechanisms of innate immune memory, otherwise known as trained immunity,
underlying its observed, pathogen-agnostic, protective health effects in early life. The candidate is currently an
Instructor of Pediatrics at Harvard Medical School in the Department of Neonatology at Beth Israel Deaconess
Medical Center, and Associate Scientist at the Precision Vaccines Program in Boston Children’s Hospital (BCH).
The outlined proposal builds on the candidate’s previous research on in vitro modeling of human leukocyte
responses to BCG vaccine formulations and complements her clinical training as a Neonatologist. Under the
mentorship of Dr. Ofer Levy, a human immunology and vaccinology expert at BCH, and complementary guidance
by an Advisory Committee, the candidate will characterize novel immunometabolic mechanisms of BCG vaccine-
induced trained immunity in newborns. The proposed experiments and didactic work will provide the candidate
with a unique intellectual framework and skill set at the intersection of newborn immunology, trained immunity
and systems biology that will facilitate her transition to independence as a translational pediatric vaccinologist.
Infectious diseases are leading causes of neonatal morbidity and mortality, due in part to a distinct immune
system at this developmental stage. The live attenuated Mycobacterium bovis vaccine BCG is given at birth to
millions of newborns worldwide to prevent severe forms of tuberculosis (TB). Epidemiologic studies demonstrate
that BCG confers a mortality benefit to immunized newborns when administered early in life, attributed to
protection vs. non-TB respiratory infections and sepsis. The mechanisms underlying BCG beneficial health
effects in early life are incompletely characterized, while in adults epigenetic and metabolic reprogramming of
monocytes have been implicated. This proposal will investigate the immunometabolic signatures of BCG-induced
trained immunity in human newborns, who manifest distinct immunity and bioenergetic demands. The proposed
study is based on preliminary data demonstrating distinct immunometabolic rewiring in human newborns and
their leukocytes after BCG immunization producing key age-specific signatures of BCG-induced trained
immunity. More specifically, the aims of this proposal are to: 1) Characterize BCG-induced immunometabolic
pathways of trained immunity in human newborn monocytes using a novel in vitro platform established by the
candidate; 2) Leverage an in vivo cohort to identify and validate metabolic pathways that may drive trained
immunity in BCG-immunized human neonates; and 3) Mechanistically probe age-specific metabolic pathways of
BCG-induced trained immunity in vitro.
The proposed project, linking expertise in neonatology, immunology, metabolism, vaccinology and systems
biology will dissect cellular and molecular mechanisms of BCG-induced trained immunity in early life, thereby
providing fresh insights to inform future early life vaccine development.
项目摘要/摘要
该提案提出了一项为期5年的研究职业发展计划,重点是研究巴奇·塞莱特(Bacille Calmette)
Guérin(BCG)疫苗和先天免疫记忆的机制,也称为受过训练的免疫,
在早期生命中,其观察到的,病原体敏锐的,受保护的健康影响。候选人当前是
哈佛医学院的儿科讲师在贝丝·以色列执事部的新生儿学系
医疗中心,以及波士顿儿童医院(BCH)精密疫苗计划的副科学家。
概述的提案基于候选人先前关于人类白细胞体外建模的研究
对BCG疫苗配方的反应,并补充了她作为新生儿医生的临床培训。在
BCH的人类免疫学和疫苗学专家Ofer Levy博士和互补指导
由咨询委员会委员会,候选人将表征BCG疫苗的新型免疫代谢机制 -
诱导新生儿训练有素的免疫力。拟议的实验和教学工作将为候选人提供
在新生儿免疫学的交汇处,具有独特的智力框架和技能,训练有素的免疫学
和系统的生物学,可以促进她过渡到独立为转化小儿疫苗科医生的独立性。
传染病是新生儿发病率和死亡率的主要原因,部分是由于独特的免疫力
在这个发展阶段的系统。活体减弱的牛分枝杆菌bcg在出生时给予
全世界数百万新生儿,以防止严重的结核病(TB)。流行病学研究表明
BCG承认生命早期管理时免疫新生儿的死亡率受益
保护与非TB呼吸道感染和败血症。 BCG有益健康的基础机制
早期的影响未完全表征,而在成年人中,表观遗传和代谢重编程
已暗示单核细胞。该建议将研究BCG诱导的免疫代谢特征
在人类新生儿中受过训练的免疫学,他们表现出明显的免疫学和生物能量需求。提议
研究基于初步数据,证明了人类新生儿中明显的免疫代谢重新定位和
BCG免疫后,其白细胞产生了BCG诱导的训练有素的特定年龄特异性签名
免疫。更具体地说,该提案的目的是:1)表征BCG诱导的免疫代谢
人类新生单核细胞中受过训练的免疫力的途径,使用由小说的体外平台建立
候选人; 2)利用体内队列来识别和验证可能驾驶训练的代谢途径
BCG免疫的人类新生儿的免疫力; 3)机械探测器特异性的代谢途径
BCG诱导的体外训练有素的免疫力。
拟议的项目将新生儿学,免疫学,代谢,疫苗学和系统的专业知识联系起来
生物学将剖析BCG诱导的早期训练的免疫的细胞和分子机制,从而
提供新的见解,以告知未来的早期生命疫苗开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Asimenia Angelidou其他文献
Asimenia Angelidou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Impact of Diet Induced Obesity on Acute Lung Injury
饮食引起的肥胖对急性肺损伤的影响
- 批准号:
10548843 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
Impact of Diet Induced Obesity on Acute Lung Injury
饮食引起的肥胖对急性肺损伤的影响
- 批准号:
10371363 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
Impact of Diet Induced Obesity on Acute Lung Injury
饮食引起的肥胖对急性肺损伤的影响
- 批准号:
10632732 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
PRDM16 regulation of metabolism in the intestinal stem cell niche
PRDM16对肠道干细胞生态位代谢的调节
- 批准号:
9977542 - 财政年份:2020
- 资助金额:
$ 17.75万 - 项目类别:
PRDM16 regulation of metabolism in the intestinal stem cell niche
PRDM16对肠道干细胞生态位代谢的调节
- 批准号:
10553635 - 财政年份:2020
- 资助金额:
$ 17.75万 - 项目类别: